Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Summary

RATIONALE: Methylphenidate may decrease side effects of radiation therapy. It is not yet known if methylphenidate is effective in improving quality of life in patients with primary or metastatic brain tumors. PURPOSE: Randomized phase III trial to determine the effectiveness of methylphenidate in improving quality of life in patients who have brain tumors and are undergoing radiation therapy.

Timeline

Start

2002-04-01

Primary completion

2005-03-01

Completion

2006-05-01

Drugs

Indications